UroCor Labs

Joint Commission Accreditation Survey

UroScoreSM

Benefit from UroCor LabsSM UroScoreSM, a consultative staging algorithm for prostate cancer available only from UroCor LabsSM.  Using this information can help you make the best treatment decisions for your patients.

View Full Size UroScoreSM Report

Full size image may take 30 seconds or more to load. It will load into a new browser window.

Back to UroServices

More Info/Rep Visit

Based on information extracted from systematic sextant biopsy

- Gleason Score

- Presence of Gleason pattern 4/5

- Number of positive cores

- Tumor location

- Average percent tumor involvement

- PSA

- Patient age

Reports probabilities that patient has organ-confined (OC), capsular penetration (CP), or advanced disease

Displays performance data

- 87% accuracy in stratifying advanced vs. OC/CP patients

- 17% increase over the accuracy of traditional clinical staging

Confirm appropriateness of curative therapy

Evaluate need for additional staging or neoadjuvant therapy